Literature DB >> 2347545

Endothelial cell transformation in primary biliary cirrhosis: a morphological and biochemical study.

C Babbs1, N Y Haboubi, J M Mellor, A Smith, B P Rowan, T W Warnes.   

Abstract

There is increasing interest in the changes of the endothelial lining of the hepatic sinusoids during the development of chronic liver disease. In this study we looked for evidence of hepatic sinusoidal endothelial cell transformation and basement membrane production in patients with primary biliary cirrhosis. Morphological transformation to vascular-type endothelial cells, as evidenced by the development VIII-related antigen, was seen at the interface between portal tracts or fibrous septae and hepatic parenchyma; the most marked changes were observed in patients with established cirrhosis. Increased immunohistochemical staining for the basement membrane components type IV collagen and laminin was also found in a similar distribution. Raised serum levels of hyaluronic acid, a glycosaminoglycan metabolized by normal hepatic endothelial cells, were found in most patients and correlated strongly with advancing histological stage. Furthermore, significant positive correlations were found between serum hyaluronic acid and serum levels of laminin and type IV collagen. The unique structure of the normal endothelial lining of the hepatic sinusoids is important in the maintenance of hepatic function. Our data show that significant changes in endothelial cell structure and function occur in primary biliary cirrhosis and appear to be a contributing factor to the progression of the disease. Further studies are needed to determine the extent and importance of these changes in other forms of chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2347545     DOI: 10.1002/hep.1840110503

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis.

Authors:  Bo Xu; Ulrika Broome; Mehmet Uzunel; Silvia Nava; Xupeng Ge; Makiko Kumagai-Braesch; Kjell Hultenby; Birger Christensson; Bo-Göran Ericzon; Jan Holgersson; Suchitra Sumitran-Holgersson
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 2.  Clinical pharmacokinetics in patients with liver disease.

Authors:  A J McLean; D J Morgan
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

Review 3.  New insights into the dynamics of sinusoidal endothelial fenestrae in liver sinusoidal endothelial cells.

Authors:  Hiroaki Yokomori
Journal:  Med Mol Morphol       Date:  2008-05-11       Impact factor: 2.309

4.  Defect of Fc receptors and phenotypical changes in sinusoidal endothelial cells in human liver cirrhosis.

Authors:  H Muro; H Shirasawa; I Kosugi; S Nakamura
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

5.  Expression of cell-cell and cell-matrix adhesion proteins by sinusoidal endothelial cells in the normal and cirrhotic human liver.

Authors:  A Couvelard; J Y Scoazec; G Feldmann
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

6.  Serum hyaluronate in patients with acute and fulminant hepatitis.

Authors:  K Suzuki; R Endo; Y Takikawa; I Nakadate; S Sato
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

7.  Factor VIII-Related Antigen Detects Phenotypic Change of Sinusoidal to Vascular Endothelium in Hepatic Fibrosis of Elderly Cadavers.

Authors:  Ki M Mak; Priya Sehgal; Cynthia K Harris
Journal:  Int Sch Res Notices       Date:  2014-09-22

Review 8.  The Endothelium as a Driver of Liver Fibrosis and Regeneration.

Authors:  Erica Lafoz; Maria Ruart; Aina Anton; Anna Oncins; Virginia Hernández-Gea
Journal:  Cells       Date:  2020-04-10       Impact factor: 6.600

Review 9.  Endothelial dysfunction in pathological processes of chronic liver disease during aging.

Authors:  Ying Wan; Xuedong Li; Elise Slevin; Kelly Harrison; Tian Li; Yudian Zhang; James E Klaunig; Chaodong Wu; Ashok K Shetty; X Charlie Dong; Fanyin Meng
Journal:  FASEB J       Date:  2022-01       Impact factor: 5.834

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.